Market Place
Sourcing Support
Corvus Presents Additional Data on Soquelitinib for T Cell Lymphoma
20 Mar 2025 //
GLOBENEWSWIRE
Corvus Starts Ph2 Trial Of Soquelitinib For ALPS Patients
12 Mar 2025 //
GLOBENEWSWIRE
Corvus Shares Phase 1 Soquelitinib Data For Atopic Dermatitis
13 Jan 2025 //
GLOBENEWSWIRE
Corvus Pharmaceuticals Announces Data from Soquelitinib Trial
18 Dec 2024 //
GLOBENEWSWIRE
Corvus Pharma Initiates Phase 3 Trial Of Soquelitinib For PTCL
10 Sep 2024 //
GLOBENEWSWIRE
Corvus Pharma Reports Q2 2024 Results And Business Update
06 Aug 2024 //
GLOBENEWSWIRE
Soquelitinib Shows Promise For Inflammatory Diseases In Preclinical Data
25 Jul 2024 //
GLOBENEWSWIRE
Corvus Provides Business Update, Q1 2024 Financial Results
06 May 2024 //
GLOBENEWSWIRE
Corvus: Soquelitinib Phase 1 Clinical Trial for Atopic Dermatitis
09 Apr 2024 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.